National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 5) (PB 48 of 2016) (Cth)

PB 48 of 2016

National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 5)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       30  May 2016

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2016 (No. 5).

   (2)   This Determination may also be cited as PB 48 of 2016.

2. Commencement

   This Determination commences on 1 June 2016.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Acamprosate

Omit

Acarbose

[2]     Schedule 1, after item dealing with Axitinib

Omit

Azacitidine

[3]     Schedule 1, after item dealing with Enzalutamide

Omit

Eplerenone

[4]     Schedule 2

Insert as first item

Acarbose

[5]     Schedule 2, after item dealing with Atorvastatin

Insert

Azacitidine

[6]     Schedule 2, after item dealing with Epirubicin

Insert

Eplerenone